Farallon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $610M | Sell |
|
|||||
|
2025
Q2 | $561M | Buy |
|
|||||
|
2025
Q1 | $515M | Sell |
|
|||||
|
2024
Q4 | $642M | Buy |
|
|||||
|
2024
Q3 | $439M | Sell |
|
|||||
|
2024
Q2 | $409M | Sell |
|
|||||
|
2024
Q1 | $463M | Sell |
|
|||||
|
2023
Q4 | $639M | Buy |
|
|||||
|
2023
Q3 | $530M | Sell |
|
|||||
|
2023
Q2 | $649M | Buy |
|
|||||
|
2023
Q1 | $605M | Sell |
|
|||||
|
2022
Q4 | $640M | Buy |
|
|||||
|
2022
Q3 | $569M | Sell |
|
|||||
|
2022
Q2 | $675M | Buy |
|
|||||
|
2022
Q1 | $723M | Buy |
|
|||||
|
2021
Q4 | $649M | Sell |
|
|||||
|
2021
Q3 | $560M | Sell |
|
|||||
|
2021
Q2 | $678M | Buy |
|
|||||
|
2021
Q1 | $527M | Buy |
|
|||||
|
2020
Q4 | $519M | Buy |
|
|||||
|
2020
Q3 | $484M | Buy |
|
|||||
|
2020
Q2 | $388M | Sell |
|
|||||
|
2020
Q1 | $353M | Buy |
|
|||||
|
2019
Q4 | $277M | Buy |
|